Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia

OBJECTIVE: An immediate-release formulation of gabapentin is approved for treatment of postherpetic neuralgia (PHN). This formulation, however, requires multiple daily dosing, usually three times per day, and is associated with a high incidence of somnolence and dizziness. We assessed the tolerabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Irving, Gordon A, Sweeney, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392710/
https://www.ncbi.nlm.nih.gov/pubmed/22792006
http://dx.doi.org/10.2147/JPR.S32562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392710/
https://www.ncbi.nlm.nih.gov/pubmed/22792006
http://dx.doi.org/10.2147/JPR.S32562

Ejemplares similares